Agios Pharmaceuticals, Inc. (AGIO)
31.32
-1.00
(-3.09%)
USD |
NASDAQ |
Oct 16, 16:00
31.29
-0.03
(-0.10%)
After-Hours: 20:00
Agios Pharmaceuticals Net Income (TTM) : -411.29M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -411.29M |
| March 31, 2026 | -422.60M |
| December 31, 2025 | -412.78M |
| September 30, 2025 | -401.26M |
| June 30, 2025 | 650.08M |
| March 31, 2025 | 665.98M |
| December 31, 2024 | 673.72M |
| September 30, 2024 | 674.31M |
| June 30, 2024 | -364.93M |
| March 31, 2024 | -352.62M |
| December 31, 2023 | -352.09M |
| September 30, 2023 | -219.62M |
| June 30, 2023 | -210.04M |
| March 31, 2023 | -218.04M |
| December 31, 2022 | -231.80M |
| September 30, 2022 | -366.91M |
| June 30, 2022 | -369.42M |
| March 31, 2022 | -360.41M |
| December 31, 2021 | -356.51M |
| September 30, 2021 | -342.47M |
| June 30, 2021 | -337.38M |
| March 31, 2021 | -336.09M |
| December 31, 2020 | -329.30M |
| September 30, 2020 | -347.11M |
| June 30, 2020 | -374.11M |
| Date | Value |
|---|---|
| March 31, 2020 | -402.49M |
| December 31, 2019 | -411.47M |
| September 30, 2019 | -400.92M |
| June 30, 2019 | -389.41M |
| March 31, 2019 | -348.28M |
| December 31, 2018 | -346.03M |
| September 30, 2018 | -342.52M |
| June 30, 2018 | -324.99M |
| March 31, 2018 | -339.33M |
| December 31, 2017 | -314.67M |
| September 30, 2017 | -282.87M |
| June 30, 2017 | -268.57M |
| March 31, 2017 | -241.44M |
| December 31, 2016 | -198.47M |
| September 30, 2016 | -182.61M |
| June 30, 2016 | -160.03M |
| March 31, 2016 | -135.97M |
| December 31, 2015 | -117.73M |
| September 30, 2015 | -103.78M |
| June 30, 2015 | -59.81M |
| March 31, 2015 | -46.21M |
| December 31, 2014 | -53.50M |
| September 30, 2014 | -39.22M |
| June 30, 2014 | -54.10M |
| March 31, 2014 | -44.43M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Biogen, Inc. | 834.60M |
| Insmed, Inc. | -875.31M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Regeneron Pharmaceuticals, Inc. | 4.329B |